APA (7th ed.) Citation

S, H., K, F., Y, K., R, N., Y, N., H, M., . . . Y, F. (2025). A Retrospective Comparison of Postoperative Tumor Necrosis Factor-α Inhibitor Continuation versus Ustekinumab Switch in Crohn's Disease: Reset or Switch? Inflammatory intestinal diseases, 10(1), 397. https://doi.org/10.1159/000549403

Chicago Style (17th ed.) Citation

S, Hosomi, et al. "A Retrospective Comparison of Postoperative Tumor Necrosis Factor-α Inhibitor Continuation Versus Ustekinumab Switch in Crohn's Disease: Reset or Switch?" Inflammatory Intestinal Diseases 10, no. 1 (2025): 397. https://doi.org/10.1159/000549403.

MLA (9th ed.) Citation

S, Hosomi, et al. "A Retrospective Comparison of Postoperative Tumor Necrosis Factor-α Inhibitor Continuation Versus Ustekinumab Switch in Crohn's Disease: Reset or Switch?" Inflammatory Intestinal Diseases, vol. 10, no. 1, 2025, p. 397, https://doi.org/10.1159/000549403.